|
|
Clinical Advantage Bootcamp: Type 1 Diabetes Management Certificate for Nurse Practitioners
|
|
Facebook
LinkedIn
E-Mail
|
Category: Diabetes, [Free CE for AANP Members], Advanced Specialty, Billing and Coding, Cert Exam Domain - Assessment, Cert Exam Domain - Diagnosis, Cert Exam Domain - Evaluation, Cert Exam Domain - Planning, Certificate, Complementary, Detailed Assessment & Documentation, Diagnostic Tests, Endocrine, Health Promotion, NP Students, Pharmacology, Primary Care, Recent Additions (show less)
Subcategory: Assessment, Best Practices, Billing and Coding, Certificate, Chronic Disease, Complementary, Detailed Assessment & Documentation, Diabetes Mellitus, Diagnosis, Diagnostic Tests, Evaluation (Follow-up), Evidence-Based Guidelines, Exam, Focused Exam, General, Guidelines, Health Behavior, Health Promotion, Hospitalist, Hyperglycemia, New Guidelines, New Medication, New Treatment, Nutrition, Pancreatic, Patient-Centered, Pediatrics, Peripheral Neuropathic Conditions, Peripheral Vascular Disease, Pharmacodynamics, Pharmacokinetics, Pharmacology, Physical Exam, Planning, Prevention, Primary Care, Renal, Risk Management, Safety, Screening, Treatment, Treatment Plan
(show less)
|
Clinical Advantage Bootcamp:
Type 1 Diabetes Management Certificate for
Nurse Practitioners
The Type 1 Diabetes Bootcamp for Nurse Practitioners equips NPs with the knowledge and confidence to lead in every aspect of type 1 diabetes care—from early recognition to advanced treatment and technology use. Through practical, evidence-based learning, participants will strengthen clinical decision-making and whole-person management skills. This program empowers nurse practitioners to transform care and outcomes for individuals living with T1D.
Overall Program Objectives:- Describe the prevalence, pathophysiology, and patient burden of type 1 diabetes (T1D), including common comorbidities and clinical complications.
- Review current standard of care best practices for T1D screening, as a means of achieving early recognition and diagnosis, and disease staging, as a means of informing treatment.
- Evaluate the established and evolving evidence for novel T1D therapeutics, with a focus on recent FDA approvals and the emerging era of disease modification.
- Examine the expanding impact of technology on T1D management, emphasizing the prominence of continuous glucose monitoring (CGM), automated insulin delivery (AID) systems, and “smart” devices across the totality of the T1D paradigm.
- Recognize the role of primary care clinicians as sentinels in the T1D management landscape, leading the charge in disease recognition, staging, and the establishment of multidisciplinary referral pathways for treatment linkage and collaborative longitudinal care.
- Discuss the harmful effects of social determinants of health (SDOH) on the overarching quality of patient-centric T1D care.
- Identify the vast psychosocial burden of T1D, highlighting best practices for mitigating this burden, managing diabetes distress, and provisioning patient support for mental and emotional health.
| IMPORTANT: This is a LARGE activity. When you first register for the activity, you will not be able to see all modules of the activity in your CE Activities list. Please wait 3-5 minutes before going to your CE Activities list to allow all of the modules time to load properly into your account. |
The State of the Science in Type 1 Diabetes: Best Practice Screening,
Staging, and Treatment Kathryn Evans-Kreider, DNP, APRN, FAANP, FNP-BC
Lucia Novak MSN, ANP-BC, BC-ADM This module is designed to provide an in-depth overview of type 1 diabetes (T1D) for primary care clinicians. It explores current epidemiology, diagnostic challenges, and the latest evidence-based practices for early screening and disease staging. The presentation also highlights emerging disease-modifying therapies, advances in diabetes technology, and the critical role of nurse practitioners in early detection, treatment coordination, and patient-centered care. Objectives:- Describe the prevalence, pathophysiology, and patient burden of type 1 diabetes (T1D), including common comorbidities and clinical complications.
- Review the current standard of care best practices for T1D screening, as a means of achieving early recognition and diagnosis, disease staging, and informing treatment.
- Recognize the role of primary care clinicians as sentinels in the T1D management landscape, leading the charge in disease recognition, staging, and the establishment of multidisciplinary referral pathways for treatment linkage and collaborative care.
Putting Type 1 Diabetes in Clinical Context: An Overview of Comorbidities
and Complications Angela Thompson DNP, FNP-C, BC-ADM, CDCES, FAANP
Nykkia Sellers DNP, FNP, BC-ADM, CDCES This module is a comprehensive exploration of the multisystem impact of type 1 diabetes (T1D). It examines acute and chronic complications—such as diabetic ketoacidosis (DKA), retinopathy, nephropathy, neuropathy, and cardiovascular disease—while emphasizing early recognition, patient education, and risk mitigation strategies. The module also highlights the importance of whole-person, primary care–driven management that integrates screening for comorbidities, psychosocial assessment, and collaboration across specialties to optimize outcomes for individuals living with T1D. Objectives:- Describe the prevalence, pathophysiology, and patient burden of type 1 diabetes (T1DM), including common comorbidities and clinical complications.
- Recognize the role of primary care clinicians as sentinels in the T1DM management landscape, leading the charge in disease recognition and staging.
- Establish multidisciplinary referral pathways for treatment linkage and collaborative care.
Examining the Evidence: Established & Emerging Type 1 Diabetes
Therapeutic Strategies Nykkia Sellers DNP, FNP, BC-ADM, CDCES
Lucia Novak MSN, ANP-BC, BC-ADM This module focuses on evidence-based and novel treatment approaches for type 1 diabetes (T1D). It provides a comprehensive review of insulin therapy—covering dosing principles, pharmacodynamics, delivery methods, and injection best practices—while emphasizing individualized glycemic goals. The presentation also explores the advent of disease-modifying and cellular therapies such as teplizumab and donislecel, illustrating how these FDA-approved innovations represent a new era in T1D management aimed at delaying disease progression and restoring beta-cell function. Objectives:- Evaluate the established and evolving evidence for novel T1D therapeutics.
- Discuss recent FDA approvals for the treatment of T1D.
- Appraise disease modification capability of emerging therapeutics.
Supporting Type 1 Diabetes Care with Technology: A Hands-On Guide Dana Roseman MPH, CDCES, RDN, LDN This module explores the expanding role of digital and device-based innovations in optimizing type 1 diabetes (T1D) management. It provides practical guidance on integrating continuous glucose monitoring (CGM), smart insulin pens, and automated insulin delivery (AID) systems into clinical practice to improve glycemic control, reduce disease burden, and enhance patient engagement. The presentation also addresses barriers to technology access and equity, emphasizing how primary care clinicians can champion the use of diabetes technologies through education, advocacy, and individualized, patient-centered implementation. Objectives:- Examine the expanding impact of hands-on use of technology on T1D management, emphasizing the prominence of continuous glucose monitoring (CGM), automated insulin delivery (AID) systems, and “smart” devices across the totality of the T1D paradigm.
Putting Knowledge Into Practice in Type 1 Diabetes: An Interactive
Case Module Angela Thompson DNP, FNP-C, BC-ADM, CDCES, FAANP This module immerses learners in real-world case scenarios across the lifespan to strengthen skills in early recognition, staging, and management of type 1 diabetes (T1D). Participants will explore current standards of care, emerging therapeutics, and the expanding role of technology and multidisciplinary collaboration in optimizing patient outcomes. Objectives:- Review the current standard of care best practices for T1D screening, as a means of achieving early recognition and diagnosis, disease staging, and informing treatment.
- Examine the expanding impact of technology on T1D management, emphasizing the prominence of continuous glucose monitoring (CGM), automated insulin delivery (AID) systems, and “smart” devices across the totality of the T1D paradigm.
- Recognize the role of primary care clinicians as sentinels in the T1D management landscape, leading the charge in disease recognition, staging, and the establishment of multidisciplinary referral pathways for treatment linkage and collaborative care.
Addressing Psychosocial Challenges and Social Determinants of Health
(SDOH) to Better Support Patients Who are Living with Type 1 Diabetes Kathryn Evans-Kreider, DNP, APRN, FAANP, FNP-BC
Korey Hood, PhD This module explores the human side of type 1 diabetes, highlighting the emotional, psychological, and social challenges faced by patients and families. Participants will learn practical, person-centered strategies to identify diabetes distress, address social determinants of health, and foster empathetic, equitable care that supports long-term well-being. Objectives:- Discuss the harmful effects of social determinants of health (SDOH) on the overarching quality of patient-centric T1D care.
- Identify the vast psychosocial burden of T1D, highlighting best practices for mitigating this burden, managing diabetes distress, and provisioning patient support for mental and emotional health.
Managing Type 1 Diabetes in Primary Care: The Paramount Placement
of the Nurse Practitioner Kathryn Evans-Kreider, DNP, APRN, FAANP, FNP-BC
Angela Thompson DNP, FNP-C, BC-ADM, CDCES, FAANP This module empowers nurse practitioners to lead the early recognition, diagnosis, and management of type 1 diabetes across care settings. Through a case-based approach, learners will explore evidence-based strategies for differential diagnosis, insulin and technology management, and addressing psychosocial and health equity factors that shape T1D outcomes. Objectives:- Recognize the role of primary care clinicians as sentinels in the T1D management landscape.
- Identify T1D in patients at risk for disease.
- Evaluate laboratory data and clinical signs to determine T1D stage.
- Devise a multidisciplinary referral pathways for treatment linkage and collaborative care.
- Individualize medication management plan based on A1C and TIR goals, risk of DKA and diabetes co-morbid conditions.
| Content Expires: | November 30, 2027 (11:55 p.m. CT)
CE for this activity will not be available after this date. |
|  | This activity includes closed captioning / transcription. |
|
Accreditation Information
This activity is approved for 8.06 contact hours of continuing education (which includes 1.63 hours of pharmacology) by the American Association of Nurse Practitioners®. Activity IDs #25107525, #25107526, #25107527, #25107528, #25107529, #25107530, #25107531. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Are you a dietitian, RN, PA, pharmacist or physician interested in obtaining AAPA, ANCC, ACPE, ACCME or CDR credit for this activity? Please use the following link to take the course through ADCES as they are providing these additional accreditation types: https://www.adces.org/store/certificate-programs/detail/clinical-advantage-bootcamp-type-1-diabetes-management-certificate
How to Complete this Activity
- Read the module descriptions, objectives, and disclosure information.
- Complete each module of educational content:
- This activity contains 3 different content-delivery types: on-demand video presentations (M1, M2, M3, M4, M7), interactive SCORM presentation (M5), and podcast (M6).
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content in each section.
- Interactive SCORM Presentations: Click the Play button to launch the interactive activity presentation. The activity will launch in a new window (make sure all popup blockers for the browser are turned off). Read all lessons and answer all interactive components of the activity. Learners must make it to the last page of the SCORM activity to trigger the "complete" status to be sent to the learning management system. Close the presentation window and immediately click on the blue "Next Steps" button for the activity block to confirm your completion. (Important Note: DO NOT relaunch the content until you have clicked the "Next Steps" button. Doing so could cause your "completion" status to not be sent to the learning management system.)
- Podcast: Click the Play button to be taken to the NP Pulse podcast on Podbean. If you have a different podcast provider that you prefer, launch your preferred podcast app and search for "NP Pulse". Listen to all of the podcast episode. A participation code will be provided at the end. Make sure to write this code down! You will need this code to unlock access to the post-test. The code will consist of a WORD and NUMBERS. When entering the code in the Participation Code field, make sure you enter the WORD and NUMBERS together (no space between them). Letters are not case sensitive.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- Click on the Next Steps button of each module. A new window will open. In this window, you will be asked to:
- Provide and submit the Participation Code, exactly as it was given in the activity, in the available text field. (Only for podcast modules)
- Complete a post-test.
- Submit the module evaluation to receive full CE/Rx credit and your certificate of completion for that module.
- Click on the "Get Certificate" button that appears at the bottom of the Next Steps window. Use the drop-down menu at the top of the next screen to select Clinical Advantage Bootcamp: Type 1 Diabetes Management Module Certificate. A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you and will be stored in your CE Tracker along with your CE/Rx credit.
- If you complete all 7 modules of educational content, go to the activity block labeled FULL PROGRAM CERTIFICATE (bottom block in the activity group) and click on the Next Steps button:
- Submit the overall program evaluation.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select Clinical Advantage Bootcamp: Type 1 Diabetes Management FULL PROGRAM Certificate.
- A copy of your certificate of completion for the full program will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- Please note that the overall program certificate is a non-credit-bearing certificate (all CE earned for the activity is reflected on the individual module certificates).
Note: This is a multi-module series that does not require linear completion of module content. Learners can complete any module in any order. A credit-bearing certificate of completion and continuing education (CE) credit will be awarded for each module completed. If a learner completes all modules of the program, they will have the option to complete a final program evaluation and earn a non-credit-bearing certificate of completion that summarizes the completion of the full program.
Disclosure, Funding and Disclaimer Information
This program was planned in accordance with AANP CE Standards and Policies.
All Planners have no relevant financial relationships to disclose.
Faculty Disclosures:
- Kathryn Evans-Kreider
- Madrigal Pharmaceuticals (Consultant/Advisor)
- Lucia Novak
- Abbott Diabetes Care (Diabetes) - Speaker, Advisory Board
- Ascensia (Diabetes) - Advisory Board
- Nestle (Obesity) - Speaker, Consutant
- Novo Nordisk (Diabetes) - Speaker, Consultant, Advisory Board
- Sanofi (Diabetes) - Speaker, Advisory Board
- Angela Thompson
- Discloses receiving travel expense funding from Tandem Diabetes Care.
- Nykkia Sellers
- No relevant disclosures to report.
- Dana Roseman
- No relevant disclosures to report.
- Korey Hood
- Sanofi (Diabetes) - Consultant
- Havas Health (Health Promotion) - Consultant
- MannKind (Diabetes) - Advisory Board, Consultant
- Embecta (Diabetes) - Researcher
Funding:
This collaboration between AANP and Danatech (an Association of Diabetes Care and Education Specialists (ADCES) initiative is made possible thanks to grants from Helmsley Charitable Trust, Abbott and Medtronic.
Disclaimer:
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
8.06 Contact Hour(s) of CE,
1.63 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
